CD274 and neoplasm: Poggio et al. showed that eliminating EVs by knocking out Rab27 or nSMase2, which are factors related to EV biogenesis, inhibits tumor progression in vivo because tumor cells secrete a vast majority of PD-L1 molecules in EVs rather than maintaining PD-L1 molecules on their cell surface.